Top 10 Surgical Solutions Solution Providers 2024
Healthcare costs have been consistently rising, straining the budgets of individuals, families, and governments. Access to quality health care is not equitable, with disparities based on factors such as income, race, geography, and education. These escalating costs can lead to financial hardships and reduced access to care. The rapid advancement of healthcare technology, particularly in areas like telemedicine, companion apps, and data analytics, presents opportunities to make health care more Read More…
In the world of advanced wound care, Kerecis, a biotechnology company founded in Iceland, has emerged as a pioneering force. The company’s innovative use of fish skin technology is revolutionizing wound healing and regenerative medicine. This profile delves into the history, mission, core values, key products, industry impact, and future prospects of Kerecis. As a company, Kerecis was founded in 2009 in Islafjordur, Iceland, by a team of visionary scientists and entrepreneurs. Read More…
Orthofix International N.V. is a global leader in the orthopedic medical device industry, specializing in innovative solutions for a wide range of musculoskeletal conditions. Founded in 1980, this Dutch-American company has consistently demonstrated a commitment to improving patients’ lives by offering advanced orthopedic products and services. This profile delves into the rich history, core values, key products, industry impact, and future prospects of Orthofix International Read More…
Through the upcoming edition of Medhealth Outlook magazine, we aim to identify the emerging talents and showcase their expertise and solutions in resolving impediments and overcoming market complexities. With regard to this, a profile of the CMO, will be featured in the magazine along with an image. This write-up is intended to shed some light to our readers, your prospective clients, and Read More…
The healthcare solutions realm is drastically adopting some of the latest technology and trends to cater to the rising regulatory requirements. As Cell and Gene Therapy evolves, reliable controls are more pressing than ever – from initial discovery to post-commercialization patient monitoring. However, traditional diagnostic controls, assay validation, and manufacturing reagents (which rely on cell lines, cell-derived products, and polystyrene beads) have limitations that leave critical gaps in the Read More…